A Semmelweis Egyetem, Tudományos és Innovációs Rektorhelyettesi és Üzletfejlesztési Központ valamint a Reumatológiai és Klinikai Immunológiai Tanszék 2023. február 2-án "Recent progress in rheumatolgy" címmel tudományos ülést tart, melynek fő előadója Georg Schett reumatológus professzor a Erlangen-nünbergi Egyetem kutatásokért felelős alelnöke és a III. sz. Belgyógyászati Klinika vezetője.

A program megtekinthető ide kattintva

Szeretettel meghívjuk Önt és Kollégáit, hogy 2023. február 9-10-én vegyen részt a Sejtek közötti és sejten belüli interakciók szerepe az immunválasz kialakításában és szabályozásában címmel rendezett és szervezett PhD (online) tanfolyamon! A nagy érdeklődésre való tekintettel meghirdettük szabadon választott tanfolyamként is a tudományos programot.

SE-TK/2023.I./00353 számon akkreditált tanfolyam , 20 kreditpont kapható a részvétellel.

Szakképesítések, amelyekhez szakma szerinti pontszámként elszámolható:
1. allergológia és klinikai immunológia | 2. bőrgyógyászat | 3. gastroenterológia | 4. klinikai farmakológia | 5. klinikai onkológia | 6. reumatológia

Semmelweis Egyetemi PhD hallgatók részére a Semmelweis Egyetem Neptun rendszerében lehet feljelentkezni január 24-ig (szoros a határidő), PhD hallgatóknak 1 kreditpont értékű.

Társegyetemekről e-mailben lehet jelentkezni a czibolya.eva.nch@gmail.com címre.

OFTEX-en való jelentkezés határideje: 2023. február 9. szabadon választható tanfolyamként

Neves előadók, érdekes program várja a résztvevőket.

A meghívó megtekinthető ide kattintva

Online tanfolyam, ezért a résztvevők részére e-mailben küldjük meg a linket, amivel csatlakozhatnak a tanfolyamhoz.

Tisztelettel várjuk Önt és Munkatársait!

Prof. Dr. Kiss Emese
egyetemi tanár
Semmelweis Egyetem

Generalised Pustular Psoriasis (GPP) – a serious rare disease and its treatment


Hereby we cordially invite you to the international webinar on Generalized Pustular Psoriasis, which will take place on June 6th from 4:00 p.m. to 5:00 p.m.

Prof. Wolf (Department of Dermatology, Medical University of Graz, Austria) and Prof. Pavlovsky (Department of Dermatology, University of Tel Aviv, Israel) will discuss the characteristics and challenges of this rare disease and concrete treatment experiences, with a focus on first experiences with spesolimab in this indication.

You can find more information about this event and the link to register in the invitation attached.

Registration:
To access the webinar, please use the following link to register for the event: REGISTRATION

After registration, you will receive an exclusive link to access the webinar

Time: Tuesday, 6th of June 2023 | 16:00-17:00 | Central European Summertime (UTC+2)

Agenda:
16:00-16:05 Welcome and Introduction
16:05-16:20 Pathophysiology, diagnosis and treatment of GPP P. Wolf
16:20-16:35 Practical treatment experiences in GPP L. Pavlovsky
16.35-17:00 Discussion

Prof. Peter Wolf, MD
Peter Wolf, MD, is Professor of Dermatology and Chair of the Department of Dermatology at the Medical University Graz, Austria. Dr. Wolf has long-standing clinical and research interests in inflammatory skin diseases including GPP. He is the principal investigator of numerous previous and ongoing clinical trials investigating novel treatment strategies in skin diseases. As an active member of the PhD programme Molecular Medicine (MOLMED) of the Medical University of Graz his translational research group addresses mechanistic issues of dermatological treatments.

Prof. Lev Pavlovsky
Dr. Lev Pavlovsky, a Clinical Associate Professor of Dermatology at Tel Aviv University‘s Medical School in Israel, is the Director of the Psoriasis Treatment Service at Rabin Medical Center. With particular expertise in immunobiological treatments, he has led several international clinical trials and authored numerous scientific publications and book chapters. Dr. Pavlovsky also serves as a Councilor at the International Psoriasis Council and the National Representative in the SPIN network.

Generalised Pustular Psoriasis (GPP) – a serious rare disease and its treatment


Hereby we cordially invite you to the international webinar on Generalized Pustular Psoriasis, which will take place on June 6th from 4:00 p.m. to 5:00 p.m.

Prof. Wolf (Department of Dermatology, Medical University of Graz, Austria) and Prof. Pavlovsky (Department of Dermatology, University of Tel Aviv, Israel) will discuss the characteristics and challenges of this rare disease and concrete treatment experiences, with a focus on first experiences with spesolimab in this indication.

You can find more information about this event and the link to register in the invitation attached.

Registration:
To access the webinar, please use the following link to register for the event: REGISTRATION

After registration, you will receive an exclusive link to access the webinar

Time: Tuesday, 6th of June 2023 | 16:00-17:00 | Central European Summertime (UTC+2)

Agenda:
16:00-16:05 Welcome and Introduction
16:05-16:20 Pathophysiology, diagnosis and treatment of GPP P. Wolf
16:20-16:35 Practical treatment experiences in GPP L. Pavlovsky
16.35-17:00 Discussion

Prof. Peter Wolf, MD
Peter Wolf, MD, is Professor of Dermatology and Chair of the Department of Dermatology at the Medical University Graz, Austria. Dr. Wolf has long-standing clinical and research interests in inflammatory skin diseases including GPP. He is the principal investigator of numerous previous and ongoing clinical trials investigating novel treatment strategies in skin diseases. As an active member of the PhD programme Molecular Medicine (MOLMED) of the Medical University of Graz his translational research group addresses mechanistic issues of dermatological treatments.

Prof. Lev Pavlovsky
Dr. Lev Pavlovsky, a Clinical Associate Professor of Dermatology at Tel Aviv University‘s Medical School in Israel, is the Director of the Psoriasis Treatment Service at Rabin Medical Center. With particular expertise in immunobiological treatments, he has led several international clinical trials and authored numerous scientific publications and book chapters. Dr. Pavlovsky also serves as a Councilor at the International Psoriasis Council and the National Representative in the SPIN network.